Results 261 to 270 of about 8,254,551 (385)

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

open access: yesMolecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang   +8 more
wiley   +1 more source

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard   +5 more
wiley   +1 more source

Perfil epidemiológico das pacientes com câncer de mama atendidas em uma unidade de saúde em São Francisco do Conde - Bahia - Brasil

open access: gold, 2015
Flávia Prazeres Reis   +4 more
openalex   +1 more source

Screening for lung cancer: A systematic review of overdiagnosis and its implications

open access: yesMolecular Oncology, EarlyView.
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz   +12 more
wiley   +1 more source

IMUNOTERAPIA NO CÂNCER DE PULMÃO: EFICÁCIA E PERSPECTIVAS DO USODE INIBIDORES DE CHECKPOINT IMUNOLÓGICO

open access: diamond
Enzo Assunção de Assis Santos   +3 more
openalex   +2 more sources

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

open access: yesMolecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece   +18 more
wiley   +1 more source

Coming to Terms with the Alcohol-Cancer Link: A Work in Progress. [PDF]

open access: yesCancer Epidemiol Biomarkers Prev
Klein WMP, Jesch E.
europepmc   +1 more source

RODA DE QUARTEIRÃO COMO ESTRATÉGIA DE FOMENTO À PREVENÇÃO DO CÂNCER DE COLO DE ÚTERO

open access: gold
CICERO AUGUSTO CARVALHO ABREU   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy